Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Key Decisions in HIV Care: Treating HIV/HCV Coinfection

Source: Key Decisions in HIV Care
Listen as Mark S. Sulkowski, MD, shares the latest data and recommendations for treating HIV and HCV in patients who are coinfected, including considerations for HCV treatment as prevention and the impact of HCV treatment on the HIV care cascade.
Released: February 16, 2022

In this episode, Mark S. Sulkowski, MD, explores recommendations and data on treating HIV and hepatitis C virus (HCV) in patients who are coinfected.

Listen as he gives his perspectives on:

  • Prioritization of both HIV and HCV treatment
  • Efficacy of HCV direct-acting antivirals in people with HIV
  • American Association for the Study of Liver Diseases/Infectious Diseases Society of America recommendations for first-line HCV treatment in HIV/HCV coinfection
  • International guidance on first-line antiretroviral therapy
  • HIV/HCV drug–drug interactions
  • The Swiss HCVree Trial of HCV treatment as prevention in men who have sex with men with HIV
  • Dependence of HCV elimination on the HIV care continuum for people who are HIV/HCV coinfected

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Information on this Educational Activity

Program Medium

This program has been made available online.

Related Content

Listen to expert faculty discuss strategies to promote ART safety and tolerability in aging patients and populations with cardiometabolic toxicities, from Clinical Care Options (CCO)

Marta Boffito, MD, PhD, FRCP Jens D. Lundgren, MD, DMSc Released: January 17, 2023

Dr Christine Katlama discusses minimizing ART exposure with dual-therapy and intermittent dosing strategies, from Clinical Care Options (CCO)

person default Christine Katlama, MD Released: January 4, 2023

Listen to Dr Princy Kumar discuss strategies on selecting between first-line ART regimens in treatment-naïve PWH, from Clinical Care Options (CCO)

Princy N. Kumar, MD, FIDSA, MACP Released: December 29, 2022

Dr Melissa Badowski shares key data about the causes of and recommendations for managing ART failure, from Clinical Care Options (CCO)

Melissa Badowski, PharmD, MPH, FIDSA, FCCP, BCIDP, BCPS, AAHIVP Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Pharmacists: 0.5 contact hours (0.05 CEUs) Released: December 23, 2022 Expired: December 22, 2023

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings